| Announce Date | 03/26/2025 |
| EPS Normalized Actual | $-1.4 (Miss by $-1.6244) |
| EPS GAAP Actual | $-1.4 (Miss by $-1.6244) |
| Revenue Actual | $0.539565B |
| Revenue Surprise | Beat by $539.565M |
| Announce Date | 12/31/1969 (Pre-Market) |
| EPS Normalized Estimate | $ |
| EPS GAAP Estimate | $ |
| Revenue Estimate | $0B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2026 | -0.36565 | -48.38 | -0.36565 | -0.36565 | 1 |
| Dec 2026 | -0.073194 | -241.69 | -0.073194 | -0.073194 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | -2.92 | -2.92 | 0.539565B | 92.13% | 487.78M |
| FQ2 2025 (Jun 2025) | -1.92 | -1.92 | 0.059406B | 31.59% | 0M |
| FQ1 2025 (Mar 2025) | -5.12 | -5.12 | 0.038537B | -645.34% | 38.54M |
| FQ4 2024 (Dec 2024) | -9.12 | -9.52622 | 0.059542B | -907.18% | -54.11M |
| FQ3 2024 (Sep 2024) | -0.82 | -2.36141 | 0.042462B | -1317.97% | -1416.31M |
| FQ2 2024 (Jun 2024) | -0.17 | -1.51259 | 0.040642B | -1495.25% | -1256.04M |
| FQ1 2024 (Mar 2024) | -1.63 | -3.20645 | 0.287231B | -124.62% | -847.37M |
| FQ4 2023 (Dec 2023) | -0.14 | -0.19 | 0.599697B | -78.71% | 395.28M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
0
EPS # of Misses
8
EPS # of in-lines
0
Revenue # of Beats
3
Revenue # of Misses
4
Revenue # of in-lines
1
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0 | -2.92 | -2.92 | 100% |
| FQ2 2025 (Jun 2025) | 0 | -1.92 | -1.92 | 100% |
| FQ1 2025 (Mar 2025) | -5.12 | -5.12 | 100% | |
| FQ4 2024 (Dec 2024) | 0.40622 | -9.12 | -9.52622 | 104.45% |
| FQ3 2024 (Sep 2024) | 1.54141 | -0.82 | -2.36141 | 287.98% |
| FQ2 2024 (Jun 2024) | 1.34259 | -0.17 | -1.51259 | 889.76% |
| FQ1 2024 (Mar 2024) | 1.57645 | -1.63 | -3.20645 | 196.71% |
| FQ4 2023 (Dec 2023) | 0.05 | -0.14 | -0.19 | 135.71% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0.05B | $0.54B | $487.78M | 90.4% |
| FQ2 2025 (Jun 2025) | $0.06B | $0.06B | $0M | 0% |
| FQ1 2025 (Mar 2025) | $0B | $0.04B | $38.54M | 100% |
| FQ4 2024 (Dec 2024) | $0.11B | $0.06B | $-54.11M | -90.88% |
| FQ3 2024 (Sep 2024) | $1.46B | $0.04B | $-1416.31M | -3335.48% |
| FQ2 2024 (Jun 2024) | $1.3B | $0.04B | $-1256.04M | -3090.51% |
| FQ1 2024 (Mar 2024) | $1.13B | $0.29B | $-847.37M | -295.01% |
| FQ4 2023 (Dec 2023) | $0.2B | $0.6B | $395.28M | 65.91% |